Advanced search
Publication Cover
Experimental Lung Research Volume 46, 2020 - Issue 5
Submit an article Journal homepage
106
Views
3
CrossRef citations to date
0
Altmetric
Articles

The expression of β-Defensin-2, IL-22, IL-22R1 and IL-10R2 in rat model of Klebsiella pneumonia and their correlation with histological grades

Jianyong FanDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
,
Yuan LuoDepartment of Respiratory Diseases, Hefei Second People’s Hospital, Hefei, Anhui Province, China;
,
Yan QinDepartment of Geriatrics Diseases, Xi’an 521 Hospital, Xi’an, Shanxi Province, ChinaCorrespondence[email protected]
,
Changgui WuDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
,
Xinpeng HanDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
,
Haifeng OuyangDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
,
Liyuan ZhangDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
,
Pei CaiDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
&
Nie LiDepartment of Respiratory Diseases, Xi’an International Medical Center, Xi’an, Shanxi Province, China;
show all
Pages 109-116 | Received 21 Nov 2019, Accepted 31 Jan 2020, Published online: 13 Mar 2020

References

  • Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. hBD-1: a novel b-defensin from human plasma. FEBS Lett. 1995;368:331–335. doi:10.1016/0014-5793(95)00687-5.
  • Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human b-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276(8):5707–5713. doi:10.1074/jbc.M008557200.
  • Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature. 1997;388(6641):416. doi:10.1038/43088.
  • Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol. 2003;74(2):180–182. doi:10.1016/S0014-4800(02)00023-0.
  • Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21(2):241–254. doi:10.1016/j.immuni.2004.07.007.
  • Wolk K, Witte E, Witte K, Warszawska K, Sabat R. Biology of interleukin-22. Semin Immunopathol. 2010;32(1):17–31. doi:10.1007/s00281-009-0188-x.
  • Froy O, Hananel A, Chapnik N, Madar Z. Differential expression of rat beta-defensins. IUBMB Life. 2005;57(1):41–43. doi:10.1080/15216540500088912.
  • Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil derived neurotoxin in host defense. Annu Rev Immunol. 2004;22(1):181–215. doi:10.1146/annurev.immunol.22.012703.104603.
  • Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989;84(2):553–561. doi:10.1172/JCI114198.
  • Routsias JG, Karagounis P, Parvulesku G, Legakis NJ, Tsakris A. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains. Peptides. 2010;31(9):1654–1660. doi:10.1016/j.peptides.2010.06.010.
  • Gong T, Jiang Y, Wang Y, et al. Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry. Arch Virol. 2010;155(4):491–498. doi:10.1007/s00705-010-0608-1.
  • Morrison G, Kilanowski F, Davidson D, Dorin J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun. 2002;70(6):3053–3060. doi:10.1128/IAI.70.6.3053-3060.2002.
  • Moranta D, Regueiro V, March C, Llobet E, Margareto J, Larrarte E. Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells. Infect Immun. 2010;78(3):1135–1146. doi:10.1128/IAI.00940-09.
  • Cireo R, Skerlavaj B, Gennam R, Amoroso A, Zanetti M. Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism. Biochem Biophys Res Commun. 2002;293(1):586–592. doi:10.1016/S0006-291X(02)00267-X.
  • Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismüller KH, Godowski PJ, et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human b defensin-2. J Immunol. 2003;171(12):6820–6826. doi:10.4049/jimmunol.171.12.6820.
  • Duits LA, Nibbering PH, Strijen E, Vos JB, Mannesse-Lazeroms SP, van Sterkenburg MA, et al. Rhinovirus increases human bdefensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol. 2003;38(1):59–64. doi:10.1016/S0928-8244(03)00106-8.
  • Diamond G, Russell JP, Bevins CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA. 1996;93(10):5156–5160. doi:10.1073/pnas.93.10.5156.
  • Kao C-Y, Chen Y, Thai P, Wachi S, Huang F, Kim C, et al. IL-17 markedly up-regulates b-defensin-2 expression in human airway epithelium via JAK and NF-kB signaling pathways. J Immunol. 2004;173(5):3482–3491. doi:10.4049/jimmunol.173.5.3482.
  • Chung WO, Hansen SR, Rao D, Dale BA. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol. 2004;173(8):5165–5170. doi:10.4049/jimmunol.173.8.5165.
  • Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203(10):2271–2279. doi:10.1084/jem.20061308.
  • Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008;14(3):275–281. doi:10.1038/nm1710.
  • Hebert KD, Mclaughlin N, Zhang Z, Cipriani A, Alcorn JF, Pociask DA. IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1. Respir Res. 2019;20(1):184. doi:10.1186/s12931-019-1153-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.